Difference Between Left-Sided and Right-Sided Colorectal Cancer: A Focused Review of Literature
Open accessThe DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Abstract
Colorectal cancer is the third most common cancer worldwide with a high mortality rate at the advanced stages. However, colorectal cancer is not a single type of tumor; its pathogenesis depends on the anatomical location of the tumor and differs between right side and left side of the colon. Tumors in the proximal colon (right side) and distal colon (left side) exhibit different molecular characteristics and histology. In the right-sided tumors, mutations in the DNA mismatch repair pathway are commonly observed; and these tumors generally have a flat histology. In the left-sided tumors, chromosomal instability pathway-related mutations, such as KRAS, APC, PIK3CA, p53 mutations are observed and these tumors demonstrate polypoid-like morphology. Therapy responses are totally different between these tumor entities. Left-sided colorectal cancer (LCRC) patients benefit more from adjuvant chemotherapies such as 5-fluorouracil (5-FU)-based regimes, and targeted therapies such as anti- epidermal growth factor receptor (EGFR) therapy, and have a better prognosis. Right-sided colorectal cancer (RCRC) patients do not respond well to conventional chemotherapies, but demonstrate more promising results with immunotherapies because these tumors have high antigenic load. For the development of effective therapy regimes and better treatment options, it is essential to evaluate right-sided and left-sided tumors as separate entities, and design the therapy regime considering the differences between these tumors. Gastroenterol Res. 2018;11(4):264-273 doi: https://doi.org/10.14740/gr1062w
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Right-sided tumors more commonly exhibit DNA mismatch repair deficiencies, while left-sided tumors often have mutations in KRAS, APC, PIK3CA, and p53 [30].”
From Update on Targeted Therapy and Immunotherapy for Metastatic Colorectal Cancer (2024) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838 · cited 1×
“highly use these regulators as an anti-tumor immune response [82, 83].”
BackgroundA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · cited 1×
“In this model, carcinogenesis begins with the inactivation or deletion of adenomatous polyposis coli (APC) tumor suppressor gene, followed by the activation of Kirsten ras homolog (KRAS) oncogene, the inactivation of p53 tumor suppressor gene and other mutations [47, 48].”
MethodPD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945 · cited 1×
“Metastatic melanoma is one of the tumors with high immunogenic load and melanoma patients are highly benefiting from anti-CTLA-4 and anti-PD-1 therapies [87, 88].”
BackgroundGenetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728 · cited 1×
“In this model, carcinogenesis begins with the inactivation or deletion of adenomatous polyposis coli (APC) tumor suppressor gene, followed by the activation of Kirsten ras homolog (KRAS) oncogene, the inactivation of p53 tumor suppressor gene and other mutations [47, 48].”
MethodType, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516 · cited 4×
“Presence of T cells in these tumors is associated with better prognosis and less frequent metastasis [12, 13, 24].”
BackgroundInfluentialImmune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
Topalian, S. L., Drake, C. G., & Pardoll, D. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.03.001 · Cited by 4,229 · cited 1×
“Interestingly, tumor infiltrating lymphocytes express high level of PD-L1, which is thought to be a result of chronic stimulation because of the neoantigen load [86].”
Background
Cited by
Items 401–500 of 581
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020
Siebenhüner, A. R. (2020) · healthbook TIMES Oncology Hematology · doi:10.36000/hbt.oh.2020.05.017 · Cited by 1
Pizarro, D. M. P., Dy, C., Ordinario, M. V. C., & Atutubo, C. M. N. (2021) · Asian Pacific Journal of Cancer Care · doi:10.31557/apjcc.2021.6.4.389-395 · Cited by 1
“This finding concurs with the literature that hereditary syndromes as cause of CRC are most often seen in the right side of the colon apart from Familial Adenomatous Polyposis (FAP) which tend to occur more in the left side [12].”
Zhou, Y., Lin, Z., Shi, M.-J., Yang, C.-Y., Wei, J., & Ke, C. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-6163 · Cited by 1
“Left- and right-sided colon cancer continue to lack unique biomarkers at present, so discovering new biomarkers is undoubtedly helpful in targeting therapies (28).”
BackgroundComparison of Resected Malignant Tumors of the Right- and Left-Sided Colon—Is There a Difference?
Kamer, E. (2022) · Indian Journal of Surgery · doi:10.1007/s12262-021-03282-3 · Cited by 1
“Despite being in the same organ (colon), the right and left colon show themselves in two different ways in terms of histopathological, molecular, embryological, carcinogenesis, microbial population, and blood supply [3, 4].”
BackgroundChronic Microinflammation as “Friendly-Fire” in Aging and Disease
Endo, Y., Ninomiya, K., & Ooi, S. L. (2023) · Springer eBooks · doi:10.1007/978-981-19-5735-2_9 · Cited by 1
Radwan, A. (2023) · ERU Research Journal · doi:10.21608/erurj.2023.200650.1015 · Cited by 1
Osman, S., Çetin, N. K., Erdoğdu, İ. H., & Meteoğlu, İ. (2023) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2023.22682 · Cited by 2
“34 The mutations involved in CRC pathogenesis differ depending on proximal or distal colon tumor, and molecular analysis is a cornerstone in the treatment and prognosis of CRCs. 35 There are 3 different molecular pathways identified so far in the pathogenesis of CRC: (i) chromosomal instability…”
BackgroundAydın, M. F., & Aydın, M. A. (2021) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.20708 · Cited by 1
Molecular genetic changes in colorectal and small bowel cancer
Hänninen, U. A. (2020) · Työväentutkimus Vuosikirja · Cited by 1
Pawlak, K. M. (2023) · Endoscopy · doi:10.1055/a-2082-8002 · Cited by 1
“Importantly, the study did not differentiate between right-sided and left-sided advanced adenoma, which could be important for tailoring surveillance strategies given the differing characteristics and prognoses of these lesions [8].”
BackgroundSATB1 Expression of Colorectal Adenomatous Polyps is Higher than that of Colorectal Carcinomas
Yalçın, G. Ş., Gönültaş, M. A., Hücümenoğlu, S., Şımşek, G., & PEKCİCİ, M. R. (2019) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000791
Kotromanović, D. (2020) · Libri Oncologici Croatian Journal of Oncology · doi:10.20471/lo.2019.47.02-03.08
Comparison of oncological results after curative resection in right and left colon cancers
Yılmaz, E. M., Karacan, E., Yıldız, B., Demir, M., & Demirkıran, A. E. (2020) · Journal of Clinical Medicine of Kazakhstan · doi:10.23950/1812-2892-jcmk-00762
“Moreover, they may present chromosomal and genetic mutational differences and differ in respect of the response to chemotherapy and the aggressive course [4].”
BackgroundDavis, M. C. (2020) · Cornerstone (Minnesota State University, Mankato)
Colorectal Peritoneal Metastases: Correlating Histopathological Findings and Disease Biology
Bhatt, A., & Gléhen, O. (2020) · Springer eBooks · doi:10.1007/978-981-15-3773-8_4 · Cited by 1
Aydın, M. F., & Aydın, M. A. (2020) · Research Square · doi:10.21203/rs.3.rs-54601/v1
“Recent studies have shown that hyperplastic polyps at the right side of the intestines may have malignant potential and should be closely followed-up [5].”
BackgroundKönig, A. O., Brunner, M., & Ellenrieder, V. (2020) · Der Onkologe · doi:10.1007/s00761-020-00888-2
“Auch wenn Karzinome, welche im linksseitigen Dickdarm von der linken Flexur bis zum Analkanal entstehen, deutlich häufiger auftreten als im rechtsseitigen Dickdarm, ist die Prognose für Krebserkrankungen im rechten Hemikolon vom Zäkum bis zur linken Flexur für betroffenen Patienten meist deutlich ungünstiger [3].”
BackgroundPalmer, M. C. L. (2021) · Mspace (University of Manitoba)
Cantero, E., Llorca, J., Cagigal, M. L., Rodríguez-Sanjuán, J. C., & Sañudo, J. A. C. (2021) · Iranian Journal of Radiology · doi:10.5812/iranjradiol.110747
Epidemiology of neoplastic colorectal polyps in a Caribbean country
Cawich, S. O., Mahabir, A., & Arthurs, M. (2021) · Medicine International · doi:10.3892/mi.2021.10
Barrett, M. (2021) · Cork Open Research Archive (University College Cork, Ireland)
Luisetto, M. (2019) · Cancer Research and Cellular Therapeutics · doi:10.31579/2640-1053/061
Dũng, N. V., & Hầu, C. H. (2022) · Tạp chí Y học Việt Nam · doi:10.51298/vmj.v509i2.1869
Гончарова, А. С., Galina, A. V., Владиславовна, Х. Д., Egorov, G. Y., Maksimov, A. Y., Kolesnikov, E. N., Komarova, E. F., Kiblitskaya, A. A., Заикина, Е. В., Kurbanova, L. Z., et al. (2022) · Research and Practical Medicine Journal · doi:10.17709/2410-1893-2022-9-1-3
YILMAZ, H., & Oktay, E. (2022) · Journal of Oncological Sciences · doi:10.37047/jos.2022-89000
Dsouza, L. L., Marla, N. J., & SHEKAR, J. C. (2021) · National Journal of Laboratory Medicine · doi:10.7860/njlm/2021/48273.2547
POTENSI miRNA SEBAGAI ALAT DIAGNOSTIK POLIP KOLON: SEBUAH TINJAUAN PUSTAKA
Jusni, L. F. J., Adiwardhana, J., & Kadharmestan, M. B. (2022) · Essential Essence of Scientific Medical Journal · doi:10.24843/estl.2021.v19.i02.p07
Lv, C., Luo, K., & Liu, S. (2022) · Journal of Oncology · doi:10.1155/2022/4637570 · Cited by 2
Dhuhani, I., Handjari, D. R., Rahadiani, N., Krisnuhoni, E., & Stephanie, M. (2022) · The Indonesian Journal of Gastroenterology Hepatology and Digestive Endoscopy · doi:10.24871/2332022194-200
IS SURVIVIN LEVEL IDENTICAL BETWEEN ADENOMAS OF PROXIMAL AND DISTAL COLON?
Adamkov, M., Csizmár, S. H., Mešťanová, V., Výbohová, D., & Krajňáková, B. (2022) · Revista Argentina de Anatomía Clínica · doi:10.31051/1852.8023.v14.n2.37625
“Hindgut gives rise to distal or left colon (left part of transverse colon, descending and sigmoid colon, and rectum) (Lim et al., 2017; Baran et al., 2018).”
Tumor localization and other factors affecting prognosis in elderly patients with colon cancer
Tuncel, E. T., & Menekşe, S. (2023) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.21471
Гончарова, А. С., Kolesnikov, E. N., Egorov, G. Y., Maksimov, A. Y., Николаевич, Ш. А., Nepomnyashchaya, E. M., Gvaldin, D. Y., Kurbanova, L. Z., Владиславовна, Х. Д., Kit, S. O., et al. (2023) · Bulletin of Siberian Medicine · doi:10.20538/1682-0363-2022-4-37-43
Hazan, D., Ishakov, A., Levi, S., Shimonov, M., & Dayan, K. (2023) · Research Square · doi:10.21203/rs.3.rs-2556167/v1
Jia, G., Lei, P., Zhang, Y., Zheng, Z., Fang, J., Yang, X., Wei, H., & Chen, T. (2023) · Pathology & Oncology Research · doi:10.3389/pore.2023.1610874
The Management of Colorectal Cancer
Henbrey, R. (2023) · Springer eBooks · doi:10.1007/978-3-031-07799-9_5
Molecular Diversity and Characteristics of KRAS Mutations in Colorectal Cancers
Kaler, A. K., Dharut, O., Umarji, S., Limaye, S., Kulkarni, B. N., Hastak, M., Athikari, N., Tiwarekar, Y., Rane, S., Nikam, A., et al. (2023) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres1650
Masrani, N., Dewi, N. N. A., Linawati, N. M., Ekawati, N. P., & Mulyawan, I. M. (2023) · European Journal of Biomedical Research · doi:10.24018/ejbiomed.2023.2.2.58
“The right-side CRC is mostly via the microsatellite instability (MSI) pathway [33].”
BackgroundBiomarkers in Colon Cancer Metastasis
Barnie, P. A., Boison, D., Amoani, B., & Su, Z. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_151-1 · Cited by 1
Documenting a case of no remaining malignant cells after neoadjuvant therapy of colorectal cancer
Fu, H., Yang, B., Yan, B., & Shu, Y. (2023) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2023.06.073
Staging and Treatment. II-1. Staging and Prognosis
Chun, H. J., Park, S. J., Lim, Y. J., & Song, S. Y. (2023) · Springer eBooks · doi:10.1007/978-981-99-0815-8_34
Фактори ризику розвитку рецидиву або продовження хвороби у хворих на колоректальний рак
Maliborska, S. V., & Holotiuk, V. V. (2023) · Art of Medicine · doi:10.21802/artm.2023.2.26.81
Relationship of Age With Right or Left Position and Colorectal Cancer Stadium
Herryanto, D., Jayadi, T., Hariatmoko, H., & Siagian, J. W. (2023) · Asian Journal of Healthy and Science · doi:10.58631/ajhs.v2i3.35
“This is aimed at improving understanding of the correlation and characteristics of each stage in an effort to determine treatment options, including effective therapy for patients (Baran et al., 2018).”
CHARACTERISTICS OF METHODS FOR CREATING ORTHOTOPIC PDX MODELS OF COLON CANCER
Гончарова, А. С., Владиславовна, Х. Д., Khudyna, Y. E., Gusareva, M. A., Сергеевич, З. М., & Александровна, У. И. (2023) · Современные проблемы науки и образования · doi:10.17513/spno.32983
A Rare Case of Cecal Adenocarcinoma Presenting as Intussusception
Javed, N., Dente, M., Ghazanfar, H., Jyala, A., & Ihimoyan, A. (2023) · Cureus · doi:10.7759/cureus.48899
“RCC is more common in women and is linked to specific risk factors, including high consumption of polyunsaturated fat, trans-fat, cholesterol, and lactose [4].”
BackgroundOrmand, A. R., Ruma, M. W., Ekawati, N. P., Mulyawan, I. M., & Dewi, N. N. A. (2023) · Intisari Sains Medis · doi:10.15562/ism.v14i1.1582
Rachmita, P. A., Hilbertina, N., Yenita, Y., Agus, S., Suchitra, A., & Yetti, H. (2023) · Majalah Patologi Indonesia · doi:10.55816/mpi.v32i3.597
Prevalence of PIK3CA Mutation Based on Tumour Locations Among Colorectal Cancer Patients in Bali
Kurniawan, N. R. A., Darwinata, A. E., & Ekawati, N. P. (2023) · International Journal of Research and Review · doi:10.52403/ijrr.20231202
Colorectal Cancer Trends and Characteristics in Tabuk, Saudi Arabia
Alghamdi, S. (2023) · Clinical Cancer Investigation Journal · doi:10.51847/sqv24bpo0n
“[32] 33-35] The study limitations were the small sample size, retrospective methods, and being a single-center study.”
BackgroundShen, C., Gu, W., & Zhou, X. (2024) · Surgery Open Science · doi:10.1016/j.sopen.2023.12.004
RetractedPeixoto, C., Lopes, M. B., Martins, M., Casimiro, S., Sobral, D., Grosso, A. R., Abreu, C., Macedo, D., Costa, A. L., Pais, H. L., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22604836
Molecular Biomarkers in Colorectal Cancer in the Era of Precision Medicine: A Review
Colombo, A., Gebbia, V., Borsellino, N., & Porretto, C. M. (2024) · International Journal of Advanced Multidisciplinary Research and Studies · doi:10.62225/2583049x.2024.4.3.2738
Maatouk, M., Mabrouk, A., Selmi, M., Khlifa, M. B., Chamakh, A., & Moussa, M. B. (2024) · Surgery Open Digestive Advance · doi:10.1016/j.soda.2024.100145
Right-side shift of colorectal cancer in Trinidad and Tobago: A change in distribution
Cawich, S. O., Muddeen, A., Barrow, M., Capildeo, K., Bhim, N., & Barrow, S. (2024) · Gastrointestinal Tract · doi:10.54844/git.2023.493
Tunçtürk, B., Alabalık, U., & Keleş, A. N. (2024) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2024.2356864
“On the other hand, mutations related to the CIN pathway such as KRAS, APC, PIK3CA, p53 mutations are observed in left-sided tumours and these tumours show polypoid-like morphology [33, 35].”
Ay, O. F., Erol, M. F., Arıcı, S., & Karadağ, M. (2024) · The European Research Journal · doi:10.18621/eurj.1455789
Incidence of lymph node metastases in colon cancer: does primary tumor location matter?
Weaver, L., Mott, S. L., Thatipelli, S., Troester, A. M., Hassan, I., Shaukat, A., & Goffredo, P. (2024) · Journal of Gastrointestinal Surgery · doi:10.1016/j.gassur.2024.05.025
Système de spectrométrie de masse in vivo pour la chirurgie guidée des cancers œsogastriques
Ledoux, L. (2023) · theses.fr (ABES) · doi:10.70675/43e7a3b8zfbacz42c5za0d9zb071f8099698
Analysis of the Clinical Incidence and Correlation between Colorectal Cancer and Microorganisms
Koutouvalis, K., & Bejarano, P. A. (2024) · American Journal of Infectious Diseases · doi:10.3844/ajidsp.2024.11.23
Ruiz-Grajales, Á. E., Correa-Cote, J. C., Pérez-García, Y. E., Fuenmayor, L. J. P., & Castrillón-Martínez, E. (2024) · Revista Colombiana de Cirugía · doi:10.30944/20117582.2576
Gendermedizin bei peritonealen Erkrankungen
Köhler, F., & Rau, B. (2024) · Die Chirurgie · doi:10.1007/s00104-024-02142-6
CodiReal-PT: National Survey on Current Practices in Right Colon Oncological Surgery
Azevedo, J., de Sousa, M. J. M. D. C. C., Cunha, M. F., Fernandez, L. M., Rama, N. J. G., & Quintanilha, R. (2024) · Journal of Coloproctology · doi:10.1055/s-0044-1788912
“5 To optimize treatment strategies and improve clinical outcomes for RCC, multidisciplinary teams (MDTs) are recommended.”
Carrick, K. S., & Zheng, W. (2024) · Springer eBooks · doi:10.1007/978-981-19-7696-4_10-1
Irawan, C., & Prasetyawaty, F. (2024) · F1000Research · doi:10.12688/f1000research.155021.1
Impact of colorectal cancer screening by primary tumor location in a real-world setting in Japan
Makiuchi, T., Zha, L., Kitamura, T., Sobue, T., & Ogawa, T. (2024) · European Journal of Cancer Prevention · doi:10.1097/cej.0000000000000940
Colorectal Cancer: A Brief and Simplified Analysis of a Complex Disease
Petrov, K., Ivanov, I. N., Popovska, S., Betova, T., & Kamburova, Z. (2024) · Medicina · doi:10.3390/medicina60122034 · Cited by 1
“In the group of patients we studied, right-sided colon cancers were found to be more common, a finding that aligns with results reported by other researchers [20,24,49].”
Torun, M., Uzun, O., Duman, M., Polat, E., Senger, A. S., Dinçer, M., Özduman, Ö., Gülmez, Ş., & Sunar, A. O. (2024) · Turkish Journal of Colorectal Disease · doi:10.4274/tjcd.galenos.2024.2024-7-3 · Cited by 1
Arora, B. (2025) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-11001
Abdullah, M., Nursyirwan, S. A., Rahadiani, N., Susanti, S., Ilyas, M., Muzellina, V. N., Idrus, M. F., & Syam, A. F. (2025) · F1000Research · doi:10.12688/f1000research.155384.1
“13 This may be attributed to the distinct gene expression profiles of the right colon, including a higher rate of immune cell infiltration and different patterns of mucin production, which might influence tumor development and immune surveillance.”
A naturally brighter approach to colorectal cancer detection
Tang-Holmes, R., Bond, W. J., Annamdevula, N. S., Verde, M., Chakroborty, D., Schuler, M., Rich, T. C., Gong, N., Sarkar, C., & Leavesley, S. J. (2025) · Imaging, Manipulation, and Analysis of Biomolecules, Cells, and Tissues · doi:10.1117/12.3042063
“Constraints to the current protocol include the turnaround time for histopathology and the limited ability to detect flat lesions and right-sided sessile serrated polyps 9 due to inadequate contrast presented by traditional white light endoscopy (WLE) 10 .”
Gibbs, P., Abubaker, K., Wang, D., Feng, Z., Hamad, J., Liao, J., Stroh, C., Vlassak, S., Heinrich, K., Khattak, A., et al. (2025) · Clinical Colorectal Cancer · doi:10.1016/j.clcc.2025.03.004 · Cited by 1
Nutritional and health status of Colorectal Cancer Patients - baseline study
Ćorić, N., Banjari, I., Rolić, T., & Marijanović, I. (2025) · THE NEW ARMENIAN MEDICAL JOURNAL · doi:10.56936/18290825-1.v19.2025-10
An overview on colonic diseases
Lentovich, C. N., Morris, J., Dominguez, D., Gittinger, M., Penny, P., & Preuss, C. V. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24806-1.00001-7
Galijašević, K., Mujezinović, A., & Denjalić, A. (2025) · Journal of Health Sciences · doi:10.17532/10.17532/jhsci.2025.2733
“In left-sided tumors, chromosomal instability pathway-related mutations such as KRAS, APC, PIK3CA, and p53 mutations are observed, and these tumors have a polypoid-like morphology (9).”
Carrick, K. S., & Zheng, W. (2025) · Springer eBooks · doi:10.1007/978-981-97-4822-8_10
Peterson, L., & Bernik, T. R. (2025) · Springer eBooks · doi:10.1007/978-3-031-78326-5_53
Asaku, B. N. A., Arko‐Boham, B., Quayson, S. E., Adams, A. R., Hooper, A., Hottor, B. A., Ahenkorah, J., Adutwum-Ofosu, K. K., & Koney, N. K. (2025) · Colorectal Cancer · doi:10.1080/1758194x.2025.2536457
Binen, T., Akbaş, E., Çolak, T., Kara, T., Bakır, A., & İnce, B. (2025) · Medical Oncology · doi:10.1007/s12032-025-02961-5
“These differences contribute to distinct pathogenic pathways and clinical outcomes based on tumor location [8, 9].”
Therapeutic approaches to pulmonary metastases in colorectal cancer
Kokhanovskaia, I. I., Fatyanova, A. S., Tarabrin, E. A., & Reshetov, I. V. (2025) · Research and Practical Medicine Journal · doi:10.17709/2410-1893-2025-12-3-6
Regulatory Role and Significance of Class V SLRPs: Podocan and Podocan-Like Protein-1
Bag, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-7890-7_7
Biomarkers in Colon Cancer Metastasis
Barnie, P. A., Boison, D., Amoani, B., & Su, Z. (2025) · Springer eBooks · doi:10.1007/978-3-032-00763-6_151
Sidedness matters: Colon cancer outcomes in low-resource settings
González‐Montero, J., Valenzuela, G., Rojas, C. I., & Burotto, M. (2025) · World Journal of Clinical Oncology · doi:10.5306/wjco.v16.i10.108937 · Cited by 2
Expression and Clinical Significance of Sideroflexin 4 (SFXN4) in Colorectal Cancer
Shamoun, L., Dimberg, J., GEIJERSTAM, K. A. F., Moltubak, E., Landerholm, K., & Wågsäter, D. (2025) · In Vivo · doi:10.21873/invivo.14134
Shen, C., Gu, W., & Zhou, X. (2025) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2025.09.026
Siitonen, H., Joensuu, J., Savolainen-Peltonen, H. M., Gissler, M., Mikkola, T. S., & Ylikorkala, O. (2025) · Maturitas · doi:10.1016/j.maturitas.2025.108802
Tsai, T.-C., Atwan, H., Yim, C., Song, J., Memon, R. S., Fahimuddin, M., Gong, C., Chang, Y., & Kumar, A. (2025) · European journal of medical research · doi:10.1186/s40001-025-03614-z
Ahmadi, M. M., Mirmazloumi, M., Saedi, H. S., & Nejatifar, F. (2025) · Gastrointestinal Nursing · doi:10.12968/gasn.2025.0107
Hydrogels Derived from Decellularized Intestines as Platforms for Studying Colorectal Cancer
Botelho, C. J. M. (2022) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/d5nk-ac56
Shi, C., Ma, J., Zhang, T., Shi, Y., Duan, W., Huang, D., Zhang, H., & Zeng, Y. (2023) · Figshare · doi:10.6084/m9.figshare.24580395
Offermans, K., Reitsam, N. G., Simons, C. C. J. M., Grosser, B., Zimmermann, J., Grabsch, H. I., Märkl, B., & van den Brandt, P. A. (2024) · Figshare · doi:10.6084/m9.figshare.26264938
Zhu, S., Tu, J., Pei, W., Zheng, Z., 毕建军, & Feng, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26630284
Zhu, S., Tu, J., Pei, W., Zheng, Z., 毕建军, & Feng, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26630275
Zhu, S., Tu, J., Pei, W., Zheng, Z., 毕建军, & Feng, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26630299
Zhu, S., Tu, J., Pei, W., Zheng, Z., 毕建军, & Feng, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26630296
Zhu, S., Tu, J., Pei, W., Zheng, Z., 毕建军, & Feng, Q. (2024) · Figshare · doi:10.6084/m9.figshare.24417621
Kolisnik, T., Sulit, A. K., Schmeier, S., Frizelle, F., Purcell, R., Smith, A., & Silander, O. (2024) · Figshare · doi:10.6084/m9.figshare.26603593
Zhu, S., Tu, J., Pei, W., Zheng, Z., 毕建军, & Feng, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26630302
Bodalal, Z., Hong, E. K., Trebeschi, S., Kurilova, I., Landolfi, F., Bogveradze, N., Castagnoli, F., Randon, G., Snaebjornsson, P., Pietrantonio, F., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26943249
Zhu, S., Tu, J., Pei, W., Zheng, Z., 毕建军, & Feng, Q. (2024) · Figshare · doi:10.6084/m9.figshare.26630293
Metadata
- Authors
- Baran, B., Mert Ozupek, N., Yerli Tetik, N., Acar, E., Bekcioglu, O., & Baskin, Y.
- Affiliations
- Dokuz Eylül University (TR)
- ORCID
- Acar, Emine
- Venue
- Gastroenterology Research
- Publisher
- Elmer Press, Inc.
- Published
- 2018
- Volume
- 11
- Issue
- 4
- Pages
- 264-273
- ISSN
- 1918-2805 (ISSN-L)
- 1918-2813
- PMC
- PMC6089587
- OpenAlex
- W2887365295
- Cited by
- 553
- References
- 113
- Citations by year
- 2026: 62 · 2025: 59 · 2024: 117 · 2023: 76 · 2022: 66 · 2021: 90 · 2020: 56 · 2019: 25 · 2018: 2
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by-nc
- Locations
- Gastroenterology Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- left-sided colorectal cancer, right-sided colorectal cancer, tumor location, mismatch repair deficiency, chromosomal instability, KRAS mutation, APC mutation, PIK3CA mutation, TP53 mutation, adjuvant chemotherapy, 5-fluorouracil, anti-EGFR therapy, immunotherapy, prognosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.